News: NCI

Next Page »« Previous Page

Obesity Genes Linked to Uterine Cancer

Friday, January 20th, 2012

Endometrial cancer, or cancer of the uterine lining, is the most common gynecological malignancy. Obesity – defined as a body mass index (BMI) of 30 or higher – is a well-established risk factor for endometrial cancer, with obese women having a 4- to 6-times higher risk of the malignancy than nonobese women. Ryan Delahanty, Ph.D., […]

My Cancer Genome Wins Technology Award

Friday, January 13th, 2012

Vanderbilt-Ingram Cancer Center physician-scientists who created the new online medical decision support tool called “My Cancer Genome” have been named winners of a $20,000 health care technology award sponsored by the National Cancer Institute. The contest, “Using Public Data for Cancer Prevention and Control: From Innovation to Impact Developer Challenge,” was presented as part of […]

Grant Bolsters Cancer Research

Friday, January 13th, 2012

The National Cancer Institute has renewed a $4.4 million, five-year grant to fund training for senior fellows and junior faculty for careers in cancer-oriented research. The goal of the Vanderbilt Clinical Oncology Research Career Development Program is to train clinician scientists who can design and implement clinical oncology trials and lead translational research projects. The […]

VICC Named to Proteomic Cancer Research Consortium

Thursday, December 8th, 2011

A team of Vanderbilt-Ingram Cancer Center scientists, led by Daniel Liebler, Ph.D., professor of Biochemistry, Biomedical Informatics and Pharmacology, has been selected to participate in the Clinical Proteomic Tumor Analysis Consortium (CPTAC), a multi-center cancer research program created by the National Cancer Institute (NCI). Liebler will lead the Vanderbilt Proteome Characterization Center, one of five […]

MyCancerGenome Finalist for Tech Award

Friday, October 28th, 2011

MyCancerGenome, the online medical decision support tool for cancer care developed by Vanderbilt physician-scientists, has been selected as a finalist for a health care technology award. The contest, “Using Public Data for Cancer Prevention and Control: From Innovation to Impact Developer Challenge,” is sponsored by the National Cancer Institute (NCI), Division of Cancer Control and […]

Heart Protein May be Target for Colon Cancer Therapies

Friday, October 7th, 2011

A protein critical in heart development may also play a part in colon cancer progression. Research led by investigators fromVanderbilt-Ingram Cancer Center and the Vanderbilt Eye Institute suggests that the protein BVES (blood vessel endocardial substance) – which also is key in regulating corneal cells – may be a therapeutic target for halting colon cancer metastasis. The study, […]

Arteaga Earns Komen Award

Friday, October 7th, 2011

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named one of the winners of this year’s Susan G. Komen for the Cure Brinker Awards for Scientific Distinction. The Brinker Awards for Scientific Distinction were established in 1992 to recognize the efforts of […]

Heart Protein Has Role in Colon Cancer

Tuesday, September 13th, 2011

A protein critical in heart development may also play a part in colon cancer progression. Research led by investigators from Vanderbilt-Ingram Cancer Center and the Vanderbilt Eye Institute suggests that the protein BVES (blood vessel endocardial substance) – which also is key in regulating corneal cells – may be a therapeutic target for halting colon […]

Raise Cancer Awareness In Your Community

Tuesday, September 6th, 2011

While September is a special month as it marks the 10-year anniversary of the 9/11 terrorist attacks, it is also a time to raise awareness about leukemia, lymphoma, childhood cancers, prostate cancer, ovarian cancer, thyroid cancer and liver cancer. Leukemia and lymphoma affect children and adults. Leukemia is a type of cancer of the blood […]

Grant Bolsters Liver Tumor Surgery Techniques

Friday, August 26th, 2011

A team led by Vanderbilt University biomedical engineer Michael Miga, Ph.D., has been awarded a five-year, $3.1 million grant from the National Cancer Institute to enhance image-guided surgery techniques for safely removing liver tumors. While aggressive surgery is a highly effective treatment, it risks injury to the liver, which can lead to post-operative liver failure. […]